Original Research publications (8 most recent)
K Boelaert, B Torlinska, RL Holder and JA Franklyn (2010). Older subjects with hyperthyroidism present with a paucity of symptoms and signs – a large cross-sectional study. Journal of Clinical Endocrinology and Metabolism, 95: 2715-2726.
RJ Watkins, ML Read, VE Smith, GM Reynolds, L Buckley, G Lewy, MC Eggo, LS Loubiere, K JA Franklyn, K Boelaert and CJ McCabe (2010). PTTG Binding Factor – a New Gene in Breast Cancer Cancer Research, 70: 3739-3749.
K Boelaert, PR Newby, MJ Simmonds, RL Holder, JD Carr-Smith, JM Heward, A Allahabadia, M Armitage, VK Chatterjee, JH Lazarus, SHS Pearce, B Vaidya, SC Gough, and JA Franklyn (2010). Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. American Journal of Medicine, 123: 183.e1-9.
VE Smith, ML Read, A Turnell, RJ Watkins, SR James, MC Eggo, K Boelaert, JA Franklyn and CJ McCabe (2009). A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. Journal of Cell Science, 122: 3393-4302.
K Boelaert, A Syed, N Manji, RL Holder, MC Sheppard, SC Gough and JA Franklyn (2009). Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. Clinical Endocrinology, 70: 129-138.
K Boelaert, VE Smith, AL Stratford, T Kogai, LA Tannahill, JC Watkinson, MC Eggo, JA Franklyn and CJ McCabe (2007). PTTG and PBF repress the human sodium iodide symporter. Oncogene, 26: 4344-4356.
HN Pemberton, JA Franklyn, K Boelaert, SY Chan, DS Kim, C Kim, SY Cheng, S Melmed, MD Kilby and CJ McCabe (2007). Separase, securin and Rad21 in neural cell growth. Journal of Cellular Physiology 2007 Journal of Cellular Physiology, 213: 45-53.
K Boelaert, J Horacek, RL Holder, JC Watkinson, MC Sheppard and JA Franklyn (2006). Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism, 91: 4295-4301.
K Boelaert (2010). Thyroid gland: Revised guidelines for the management of thyroid cancer. Nature Reviews in Endocrinology, 6: 185-186.
K Boelaert (2010). Treatment of Graves’ disease with antithyroid drugs: Current perspectives. Thyroid, 20: 943-946.
N Sharma, K Boelaert and JC Watkinson (2010). Who should treat thyroid cancer? A UK surgical perspective. Clinical Oncology, 22:413-418
K Boelaert (2009). The association between TSH and Thyroid cancer. Endocrine Related Cancer, 16: 1065-1072.
K Boelaert and JA Franklyn. Starling Review: Thyroid hormone in health and disease. Journal of Endocrinology, 187: 1-15.
K Boelaert and NJ Gittoes. Radiotherapy for non-functioning pituitary adenomas. European Journal of Endocrinology, 144: 569-75.
K Boelaert (2010). Thyroid hormones, iodine and antithyroid drugs In Side Effects of Drugs Annual Volume 32 (in press)
K Boelaert, L Albon, and JA Franklyn (2010). Benign Thyroid Disease, In Stell and Maran's Textbook of Head and Neck Surgery and Oncology, 5th Edition (in press)
K Boelaert, JV Parle and JA Franklyn (2010). Thyroid Disease, In Endocrinology in Primary Care, pp125-165, Ed N Gittoes, National services for Health Improvement, Nuffield Press Ltd, Dartford, UK.